| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |